Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vaccine research network awarded £1.2 million grant
The network has members in 93 countries.
The network supports livestock and zoonotic vaccine research.

The International Veterinary Vaccinology Network (IVVN), based at the Roslin Institute, has been awarded a £1.2 million grant from the Medical Research Council.

The network, which is made up of more than 1,900 scientists and industry partners from 93 countries around the world, aims to help develop improved vaccines for livestock and zoonotic diseases.

It is one of five global vaccine networks which provide a collaborative platform for researchers, particularly from low and middle income countries, to share knowledge and expertise.
 
The funding will allow IVVN to provide funding for collaboration between scientists, offer training opportunities, and engage the next generation of scientists.

Dr Timothy Connelley, network director of IVVN, said: “We are delighted to have been awarded funding to continue our activities to support veterinary vaccinologists across the world.

“With this funding, we will continue efforts to bring the human and veterinary vaccine research communities together, support scientific collaboration by providing pump-priming funding, provide training for early career researchers and expand our schools outreach programme to inspire the next generation of scientists.”

Dr Mark Palmer, director of international strategy at the Medical Research Council, said: “Investing in collaborations like these will better prepare us for future disease epidemics and to more effectively tackle the slow-moving pandemic of antimicrobial resistance.

“These global networks are integral to ensuring the UK harnesses the extraordinary potential of research and innovation to enrich and improve the lives of people living in the UK and around the world.”

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.